Meningiomas, often linked to the loss of the NF2 gene, are a hallmark of NF2-SWN and can severely impact patients' lives despite being typically non-malignant. Through this new project ...

In a recent blog, I discussed the change in nomenclature for the conditions formerly known as Neurofibromatosis type 2 (NF2) and schwannomatosis. This change was based on the results of an ...

Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas Crizotinib (Xalkori®), a small molecule kinase inhibitor, ...

Low versus low-intermediate risk metastatic renal cell carcinoma (mRCC): Contemporary data from the International mRCC Database Consortium (IMDC).